Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Showcase


Channel Catalog


Channel Description:

Visit One News Page for Europe news from around the world, aggregated from leading sources including newswires, newspapers and broadcast media. Search millions of archived news headlines. This feed provides the Europe news headlines.

older | 1 | .... | 1560 | 1561 | (Page 1562) | 1563 | 1564 | .... | 1652 | newer

    0 0

    Europe has dominated Theresa May's premiership and could derail it. But as Sean O'Grady explains, she is following in a long Conservative tradition Reported by Independent 1 hour ago.

    0 0

    A new centre for "crypto-anarchy" based in Slovakia is pushing for a return to what they believe are the technology's core political tenets. Reported by Coindesk 51 minutes ago.

    0 0

    MONTREAL, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce the appointment of Mr. Jovan Antunovic as Senior Vice President and Chief Commercial Officer.“Jovan brings the expertise, experience and leadership we were looking for to bring Theratechnologies to the next level. His primary mandate will be to focus on the United States market and to ensure that we fully develop Trogarzo^® and EGRIFTA^®,” said Luc Tanguay, President and Chief Executive Officer, Theratechnologies Inc.

    “We have found in Jovan a unique blend of large and small pharma marketing and sales experience in North America, Europe and Asia, coupled to a strong understanding of the intricacies of injectable treatments and a deep knowledge of HIV. He will be able to use all these skills in his new position at Theratechnologies,” concluded Mr. Tanguay.

    Until October, Mr. Antunovic was Vice President, Specialty/Innovative Medicines Business Lead at Bristol-Myers Squibb Canada. He previously held increasingly senior positions at Abbvie, Abbott and Axcan Pharma.

    Mr. Antunovic holds a B.Sc and a M.Sc. in Biochemistry as well as a M.B.A. (Marketing), all from McGill University in Montreal.

    *About Theratechnologies *
    Theratechnologies (TSX: TH) is a specialty pharmaceutical company addressing unmet medical needs by bringing to market specialized therapies for people with orphan medical conditions, including those living with HIV. Further information about Theratechnologies is available on the Company's website at www.theratech.com and on SEDAR at www.sedar.com.

    *Forward-Looking Information *
    This press release contains forward-looking statements and forward-looking information, or, collectively, forward-looking statements, within the meaning of applicable securities laws, that are based on our management’s beliefs and assumptions and on information currently available to our management. You can identify forward-looking statements by terms such as "may", "will", "should", "could", “would”, "outlook", "believe", "plan", "envisage", "anticipate", "expect" and "estimate", or the negatives of these terms, or variations of them.

    Forward-looking statements are subject to a variety of risks and uncertainties, many of which are beyond our control that could cause our actual results to differ materially from those that are disclosed in or implied by the forward-looking statements contained in this press release.

    We refer potential investors to the "Risk Factors" section of our annual information form dated February 6, 2018 for additional risks regarding the conduct of our business and Theratechnologies. The reader is cautioned to consider these and other risks and uncertainties carefully and not to put undue reliance on forward-looking statements. Forward-looking statements reflect current expectations regarding future events and speak only as of the date of this press release and represent our expectations as of that date.

    We undertake no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise, except as may be required by applicable law.

    For media inquiries:
    Denis Boucher
    Vice President, Communications and Corporate Affairs
    514-336-7800 Reported by GlobeNewswire 2 hours ago.

    0 0

    Dublin, Dec. 03, 2018 (GLOBE NEWSWIRE) -- The "Global Waste Paper Management Market Analysis & Trends - Industry Forecast to 2027" report has been added to *ResearchAndMarkets.com's* offering.

    The Global Waste Paper Management Market is poised to grow strong during the forecast period 2017 to 2027

    Some of the prominent trends that the market is witnessing include increasing demand for paper based industry, awareness programs for waste management & optimizing commercial recycling and waste management.

    This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

    The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

    The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

    *Report Highlights:*

    · The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    · Market forecasts till 2027, using estimated market values as the base numbers
    · Key market trends across the business segments, Regions and Countries
    · Key developments and strategies observed in the market
    · Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    · In-depth company profiles of key players and upcoming prominent players
    · Growth prospects among the emerging nations through 2027
    · Market opportunities and recommendations for new investments

    *Key Topics Covered:*

    *1 Market Outline*
    1.1 Research Methodology
    1.2 Market Trends
    1.3 Regulatory Factors
    1.4 Product Analysis
    1.5 Strategic Benchmarking
    1.6 Opportunity Analysis

    *2 Executive Summary*

    *3 Market Overview*
    3.1 Current Trends
    3.1.1 Increasing Demand for Paper Based Industry
    3.1.2 Awareness Programs For Waste Management
    3.1.3 Optimizing Commercial Recycling and Waste Management
    3.1.4 Growth Opportunities/Investment Opportunities
    3.2 Drivers
    3.3 Constraints
    3.4 Industry Attractiveness

    *4 Waste Paper Management Market, By Recycled Product *
    4.1 Confetti
    4.2 Container board
    4.3 Facial Tissues
    4.4 Newspaper
    4.5 Paper Towels
    4.6 Other Recycled Products
    4.6.1 Paper plates
    4.6.2 Paperboard

    *5 Waste Paper Management Market, By Services*
    5.1 Storage
    5.2 Sorting
    5.3 Shredders
    5.4 Sheet Cutter
    5.5 Scrubbers
    5.6 Recycling
    5.7 Pulper
    5.8 Processing
    5.9 Pressing Machine
    5.10 Precipitators
    5.11 Mixers
    5.12 Incineration
    5.13 Forming Machine
    5.14 Drier
    5.15 Disposal
    5.16 De-Inking Machine
    5.17 Compactors
    5.18 Combustors
    5.19 Collection & Transportation
    5.20 Air Heater

    *6 Waste Paper Management Market, By Type*
    6.1 Recover
    6.2 Replace
    6.3 Recycle
    6.4 Reuse
    6.5 Reduce

    *7 Waste Paper Management Market, By Equipment*
    7.1 Storage Equipment
    7.2 Segregation Equipment
    7.3 Processing Equipment
    7.4 Collection & Transportation equipment

    *8 Waste Paper Management Market, By Paper Grade*
    8.1 High-Grade De-Inked Paper
    8.2 Magazines
    8.3 Mixed Papers
    8.4 Old Corrugated Containers (OCC)
    8.5 Old Newspaper (ONP)
    8.6 Pamphlets
    8.7 Pulp Substitutes

    *9 Waste Paper Management Market, By Source Of Waste Paper*
    9.1 Commercial
    9.2 Industrial
    9.3 Residential
    9.4 Other Source Of Waste Papers
    9.4.1 Institutional

    *10 Waste Paper Management Market, By Geography*
    10.1 North America
    10.1.1 US
    10.1.2 Canada
    10.1.3 Mexico
    10.2 Europe
    10.2.1 Germany
    10.2.2 U.K
    10.2.3 Italy
    10.2.4 France
    10.2.5 Spain
    10.2.6 Rest of Europe
    10.3 Asia Pacific
    10.3.1 China
    10.3.2 Japan
    10.3.3 India
    10.3.4 Australia
    10.3.5 New Zealand
    10.3.6 Rest of Asia Pacific
    10.4 Middle East
    10.4.1 Saudi Arabia
    10.4.2 UAE
    10.4.3 Rest of Middle East
    10.5 Latin America
    10.5.1 Argentina
    10.5.2 Brazil
    10.5.3 Rest of Latin America
    10.6 Rest of the World (RoW)
    10.6.1 South Africa
    10.6.2 Others

    *11 Key Player Activities*
    11.1 Acquisitions & Mergers
    11.2 Agreements, Partnerships, Collaborations and Joint Ventures
    11.3 Product Launch & Expansions
    11.4 Other Activities

    *12 Leading Companies*
    12.1 ACM Waste Management PLC
    12.2 Allied Waste Industries Inc.,Company
    12.3 Cascades Recovery Inc.,
    12.4 Eco Waste Solutions
    12.5 Harris Waste Management Group, Inc.
    12.6 Hills Waste Solutions Limited
    12.7 International Paper Company
    12.8 Macpresse Europa S.R.L
    12.9 Organic Waste Systems
    12.10 Reliable Paper Recycling, Inc
    12.11 Republic Services, Inc.
    12.12 Shanks Waste Management
    12.13 Utopia Waste Management Ltd
    12.14 Waste Management Inc.
    12.15 Zero Waste Energy, LLC.

    For more information about this report visit https://www.researchandmarkets.com/research/d3npbc/global_waste?w=12

    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Pulp and Paper, Waste Management Reported by GlobeNewswire 2 hours ago.

    0 0

    VANCOUVER, British Columbia, Dec. 03, 2018 (GLOBE NEWSWIRE) -- *Juggernaut Exploration Ltd. (TSX-V: JUGR) (Frankfurt: 4JE) (OTC: JUGRF) (the “Company or “Juggernaut”)* is pleased to announce that its non-brokered private placement of $1,650,000 announced on November 27th, 2018 was increased and closed at $1,677,800 subject to acceptance by the TSX Venture Exchange (the “Exchange”). Due to strong demand from institutions and accredited investors alike in the Americas and Europe, management is arranging a second tranche financing with closing planned for December 13 of 2018, pending final acceptance by the Exchange. Upon final acceptance Juggernaut will be funded to meet its 2019 exploration commitments on Empire, Midas, DSM and J2 projects.Mr. Dan Stuart, Director, President and CEO of Juggernaut states: “Our properties are all located in key geologic terranes that have garnered interest from the Miners and strong support from institutions alike. Drill results from Midas and Empire will be reported once received, compiled and interpreted. We look forward to the 2019 drilling and exploration season with great anticipation.”

    The offering consisted of flow-through units (each an "FT Unit") at the price of $0.18 and non-flow-through units (each an "NFT Unit") at the price of $0.16. Each FT Unit consists of one common share which is a "flow-through" share for Canadian income tax purposes and one half share purchase warrant (each half warrant a "$0.36 Warrant"). Two $0.36 half warrants entitle the holder to purchase one additional common share which is not a "flow-through" share at the price of $0.36 for 24 months after Closing. Each NFT Unit consists of one common share which is not a "flow-through" share and one share purchase warrant (each a "$0.32 Warrant"). Each $0.32 Warrant entitles the holder to purchase one additional common share which is not a "flow-through" share at the price of $0.32 for a period of 36 months after Closing. If at any time after four months after the date of completion of the offering the Company's Shares have a closing price equal to or higher than $0.72 per Share for ten (10) consecutive trading days on the TSX-V (as defined herein), the Company shall thereafter be entitled to give notice to the holders of all $0.36 Warrants, by news release, that such warrants will expire at 4:30 p.m. (Toronto time) on that date which is 30 days after the date of such news release unless exercised before the expiry of that period. If at any time after four months after the date of completion of the offering the Company's Shares have a closing price equal to or higher than $0.80 per Share for ten (10) consecutive trading days on the TSX-V (as defined herein), the Company shall thereafter be entitled to give notice to the holders of all $0.32 Warrants, by news release, that such warrants will expire at 4:30 p.m. (Toronto time) on that date which is 30 days after the date of such news release unless exercised before the expiry of that period. The completed financing consisted of 3,479,375 in non-flow-through units for gross proceeds of $556,700 and 6,228,333 of the flow-through units for gross proceeds of $1,121,100.

    The Company will pay finder's fees equal to 5% of the gross proceeds from a portion of the financing in cash, and 5% finder’s warrants equal to the number of units sold in accordance with the policies of the Exchange.  Subject to acceptance by the Exchange, the Company will pay a total of $68,240 in finders’ fees, 76,157 and 300,417 in finders’ warrants in relation to the non flow-through and flow-through units sold respectively. These warrants are priced and have the same terms as the warrants attached to the respective units sold.

    All shares issued pursuant to the offering and any shares issued pursuant to the exercise of warrants (including warrants issued to finders) will be subject to a four-month hold period from the closing date.

    Further information regarding Juggernaut Exploration Ltd. can be found at
    JuggernautExploration.com

    *Contact Information:*

    Dan Stuart Director, President, and CEO
    dan@JuggernautExploration.com
    +1-604-559-8028

    Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

    Juggernaut Exploration Ltd.
    Suite 1010-1130 West Pender St.
    Vancouver BC V6E-4A4
    Office # 1-604-559-8028
    Fax # 1-604-681-1864 Reported by GlobeNewswire 1 hour ago.

    0 0

    Dublin, Dec. 03, 2018 (GLOBE NEWSWIRE) -- The "Global Packaging Machinery Market Analysis & Trends - Industry Forecast to 2027" report has been added to *ResearchAndMarkets.com's* offering.

    The Global Packaging Machinery Market is poised to grow strong during the forecast period 2017 to 2027

    Some of the prominent trends that the market is witnessing include Emergence of robotic packaging and automation, growing use of pneumatic technology in packaging machinery and Increase in development of new products.*
    *
    This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

    The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
    *Scope of the Report*· Based on the Material Type, the market is divided into Case Forming, Packing, &Sealing Machinery, Filling & Form/Fill/Seal Machinery, Labeling & Coding Machinery, Packaging Machinery Parts and Wrapping, Bundling, & Palletizing Machinery.
    · On the basis of the Type, the market is divided into Closing & Sealing, Form Fill Seal, Labelling & Coding and Wrapping & Bundling.
    · By Application, the market is bifurcated into Beverages, Chemical Products, Food, Pharmaceuticals & Personal Care Products and Other Applications.

    *Report Highlights:*

    · The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    · Market forecasts till 2027, using estimated market values as the base numbers
    · Key market trends across the business segments, Regions and Countries
    · Key developments and strategies observed in the market
    · Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    · In-depth company profiles of key players and upcoming prominent players
    · Growth prospects among the emerging nations through 2027
    · Market opportunities and recommendations for new investments

    *Key Topics Covered:*

    1 Market Outline
    1.1 Research Methodology
    1.1.1 Research Approach & Sources
    1.2 Market Trends
    1.3 Regulatory Factors
    1.4 Application Analysis
    1.5 Strategic Benchmarking
    1.6 Opportunity Analysis

    2 Executive Summary

    3 Market Overview
    3.1 Current Trends
    3.1.1 Emergence of robotic packaging and automation
    3.1.2 Growing use of pneumatic Type in packaging machinery
    3.1.3 Increase in development of new products
    3.1.4 Growth Opportunities/Investment Opportunities
    3.2 Drivers
    3.3 Constraints
    3.4 Industry Attractiveness

    4 Packaging Machinery Market, By Material Type
    4.1 Case Forming, Packing, & Sealing Machinery
    4.2 Filling & Form/Fill/Seal Machinery
    4.3 Labeling & Coding Machinery
    4.4 Packaging Machinery Parts
    4.5 Wrapping, Bundling, & Palletizing Machinery

    5 Packaging Machinery Market, By Type
    5.1 Closing & Sealing
    5.2 Form Fill Seal
    5.3 Labelling & Coding
    5.4 Wrapping & Bundling

    6 Packaging Machinery Market, By Application
    6.1 Beverages
    6.2 Chemical Products
    6.3 Food
    6.4 Pharmaceuticals & Personal Care Products
    6.5 Other Applications

    7 Packaging Machinery Market, By Geography
    7.1 North America
    7.1.1 US
    7.1.2 Canada
    7.1.3 Mexico
    7.2 Europe
    7.2.1 Germany
    7.2.2 U.K
    7.2.3 Italy
    7.2.4 France
    7.2.5 Spain
    7.2.6 Rest of Europe
    7.3 Asia Pacific
    7.3.1 China
    7.3.2 Japan
    7.3.3 India
    7.3.4 Australia
    7.3.5 New Zealand
    7.3.6 Rest of Asia Pacific
    7.4 Middle East
    7.4.1 Saudi Arabia
    7.4.2 UAE
    7.4.3 Rest of Middle East
    7.5 Latin America
    7.5.1 Argentina
    7.5.2 Brazil
    7.5.3 Rest of Latin America
    7.6 Rest of the World (RoW)
    7.6.1 South Africa
    7.6.2 Others

    8 Key Player Activities
    8.1 Acquisitions & Mergers
    8.2 Agreements, Partnerships, Collaborations and Joint Ventures
    8.3 Product Launch & Expansions
    8.4 Other Activities

    9 Leading Companies· GEA Group
    · Illinois Tool Works
    · Krones AG (Germany)
    · Robert Bosch
    · Reynolds Group Holdings (New Zealand)
    · Tetra Level International (Switzerland)
    · Sato Holdings Corporation (Japan)
    · Pro Mach, Inc. (U.S)
    · Nordson Corporation (U.S.)
    · MULTIVAC Group (U.S)
    · Mamata Enterprises (India)
    · Graphic Packaging Holding (U.S)
    · Dover Corporation (U.S.)
    · Automated Packaging Systems (U.S)
    · GEA Group AG (Germany)
    · Barry-Wehmiller Companies

    For more information about this report visit https://www.researchandmarkets.com/research/z8xn4f/global_packaging?w=12

    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Packaging, Industrial Machinery Reported by GlobeNewswire 1 hour ago.

    0 0

    GlaxoSmithKline PLC (LON:GSK) has agreed to buy US cancer drug maker Tesaro Inc (NASDAQ:TRO) for US$5.1bn, hot on the heels of announcing the US$3.8bn sale of its Indian Horlicks business to Unilever plc (LON:ULVR). The FTSE 100 firm said the proposed acquisition would strengthen its pharmaceuticals business by building its drugs pipeline and commercial capability in oncology. Tesaro’s key drug Zejula is currently approved for use in the treatment of adult patients with ovarian cancer in the US and Europe.  Zejula is currently being investigated for use as a possible treatment in lung, breast and prostate cancer.  Tesaro’s pipeline of drugs includes Niraparib for the treatment of ovarian and breast cancer and Rolapitant IV for the prevention of delayed nausea and vomiting associated with chemotherapy. “This combination will support our aim to deliver long-term sustainable growth and is consistent with our capital allocation priorities. We look forward to working with TESARO's talented team to bring valuable new medicines to patients,” said GSK chief executive Emma Walmsely. The announcement comes a few hours after GSK said it had completed the sale of its Indian Horlicks nutrition business to consumer goods giant Unilever plc (LON:ULVR). READ: GlaxoSmithKline sells Indian Horlicks business to Unilever The deal covers GSK’s health food and drinks portfolio in India, Bangladesh, and 20 other markets predominantly in Asia and includes its 72.5% stake in India-listed GlaxoSmithKline Consumer Healthcare. Following the transaction, GSK will hold a 5.7% stake in HUL which it intends to sell in tranches at times it considered appropriate. Reported by Proactive Investors 1 hour ago.

    0 0

    GlaxoSmithKline PLC (LON:GSK) has agreed to buy US cancer drug maker Tesaro Inc (NASDAQ:TRO) for US$5.1bn, hot on the heels of announcing the US$3.8bn sale of its Indian Horlicks business to Unilever plc (LON:ULVR). The FTSE 100 firm said the proposed acquisition would strengthen its pharmaceuticals business by building its drugs pipeline and commercial capability in oncology. Tesaro’s key drug Zejula is currently approved for use in the treatment of adult patients with ovarian cancer in the US and Europe.  Zejula is currently being investigated for use as a possible treatment in lung, breast and prostate cancer.  Tesaro’s pipeline of drugs includes Niraparib for the treatment of ovarian and breast cancer and Rolapitant IV for the prevention of delayed nausea and vomiting associated with chemotherapy. “This combination will support our aim to deliver long-term sustainable growth and is consistent with our capital allocation priorities. We look forward to working with TESARO's talented team to bring valuable new medicines to patients,” said GSK chief executive Emma Walmsely. The announcement comes a few hours after GSK said it had completed the sale of its Indian Horlicks nutrition business to consumer goods giant Unilever plc (LON:ULVR). READ: GlaxoSmithKline sells Indian Horlicks business to Unilever The deal covers GSK’s health food and drinks portfolio in India, Bangladesh, and 20 other markets predominantly in Asia and includes its 72.5% stake in India-listed GlaxoSmithKline Consumer Healthcare. Following the transaction, GSK will hold a 5.7% stake in HUL which it intends to sell in tranches at times it considered appropriate. Reported by Proactive Investors 1 hour ago.

    0 0
  • 12/03/18--04:52: Net Asset Value(s)
  • *WisdomTree Issuer plc – Daily Fund Prices * *30-November-18*
    * * * *

                   

    Fund Dealing Date ISIN Code Shares Base Net Assets NAV/Share
          in Issue Currency    
    WisdomTree AT1 CoCo Bond UCITS ETF  – USD 30/11/2018 IE00BZ0XVF52 268045 USD 24,825,888.27 92.6184
    WisdomTree AT1 CoCo Bond UCITS ETF – EUR Hedged 30/11/2018 IE00BFNNN236 20828 EUR 2,015,248.40 96.7567
    WisdomTree AT1 CoCo Bond UCITS ETF – GBP Hedged 30/11/2018 IE00BFNNN459 20740 GBP 2,014,762.28 97.1438
    WisdomTree AT1 CoCo Bond UCITS ETF – USD Acc 30/11/2018 IE00BZ0XVG69 9000 USD 837,284.50 93.0316
    WisdomTree AT1 CoCo Bond UCITS ETF – USD Hedged 30/11/2018 IE00BFNNN012 20962 USD 2,045,502.31 97.5814
    WisdomTree CBOE S&P 500 PutWrite UCITS ETF - USD Acc 30/11/2018 IE00BD49R243 1680000 USD 84,034,670.14 50.0206
    WisdomTree Emerging Asia Equity Income UCITS ETF 30/11/2018 IE00BYPGT035 1125000 USD 12,119,728.34 10.7731
    WisdomTree Emerging Markets Equity Income UCITS ETF 30/11/2018 IE00BQQ3Q067 1917097 USD 28,658,042.94 14.9487
    WisdomTree Emerging Markets Equity Income UCITS ETF Acc 30/11/2018 IE00BDF12W49 108242 USD 2,045,098.93 18.8938
    WisdomTree Emerging Markets Small Cap Dividend UCITS ETF 30/11/2018 IE00BQZJBM26 1375000 USD 22,272,409.51 16.1981
    WisdomTree Enhanced Commodity UCITS ETF – EUR Hedged Acc 30/11/2018 IE00BG88WG77 25000 EUR 237,816.20 9.5126
    WisdomTree Enhanced Commodity UCITS ETF – GBP Hedged Acc 30/11/2018 IE00BG88WH84 1425000 GBP 13,605,546.80 9.5478
    WisdomTree Enhanced Commodity UCITS ETF - USD 30/11/2018 IE00BZ1GHD37 475000 USD 4,780,122.12 10.0634
    WisdomTree Enhanced Commodity UCITS ETF - USD Acc 30/11/2018 IE00BYMLZY74 23525000 USD 237,777,082.30 10.1074
    WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR 30/11/2018 IE00BD49R912 30000 EUR 1,483,171.22 49.439
    WisdomTree EUR Aggregate Bond Enhanced Yield UCITS ETF – EUR Acc 30/11/2018 IE00BD49RB39 30000 EUR 1,483,172.37 49.4391
    WisdomTree EUR Government Bond Enhanced Yield UCITS ETF 30/11/2018 IE00BD49RJ15 30000 EUR 1,489,282.92 49.6428
    WisdomTree EUR Government Bond Enhanced Yield UCITS ETF – EUR Acc 30/11/2018 IE00BD49RK20 30000 EUR 1,489,283.40 49.6428
    WisdomTree Europe Equity Income UCITS ETF 30/11/2018 IE00BQZJBX31 3633600 EUR 45,196,624.26 12.4385
    WisdomTree Europe Equity Income UCITS ETF Acc 30/11/2018 IE00BDF16007 40010 EUR 568,290.68 14.2037
    WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc 30/11/2018 IE00BYQCZT11 17096 CHF 266,152.10 15.5681
    WisdomTree Europe Equity UCITS ETF - EUR Acc 30/11/2018 IE00BYQCZX56 604306 EUR 9,554,275.51 15.8103
    WisdomTree Europe Equity UCITS ETF - GBP Hedged 30/11/2018 IE00BYQCZQ89 342454 GBP 3,557,017.61 10.3868
    WisdomTree Europe Equity UCITS ETF - USD Hedged 30/11/2018 IE00BVXBH163 3135804 USD 51,581,266.36 16.4491
    WisdomTree Europe Equity UCITS ETF - USD Hedged Acc 30/11/2018 IE00BYQCZP72 3995137 USD 74,080,519.97 18.5427
    WisdomTree Europe Small Cap Dividend UCITS ETF 30/11/2018 IE00BQZJC527 3440006 EUR 53,706,690.53 15.6124
    WisdomTree Europe Small Cap Dividend UCITS ETF Acc 30/11/2018 IE00BDF16114 656066 EUR 8,886,921.55 13.5458
    WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR 30/11/2018 IE00BZ56SY76 416881 EUR 5,697,681.94 13.6674
    WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc 30/11/2018 IE00BZ56TQ67 938013 EUR 14,163,520.38 15.0995
    WisdomTree Germany Equity UCITS ETF - CHF Hedged Acc 30/11/2018 IE00BYQCZ914 45884 CHF 772,079.16 16.8268
    WisdomTree Germany Equity UCITS ETF - EUR Acc 30/11/2018 IE00BYQCZC44 251123 EUR 3,761,869.52 14.9802
    WisdomTree Germany Equity UCITS ETF - GBP Hedged 30/11/2018 IE00BVXBGY20 507894 GBP 4,771,058.82 9.3938
    WisdomTree Germany Equity UCITS ETF - USD Hedged 30/11/2018 IE00BYQCZ682 17536 USD 293,329.22 16.7273
    WisdomTree Global Quality Dividend Growth UCITS ETF - USD 30/11/2018 IE00BZ56RN96 63688 USD 1,273,849.09 20.0014
    WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc 30/11/2018 IE00BZ56SW52 454761 USD 9,443,051.00 20.7649
    WisdomTree India Quality UCITS ETF - USD 30/11/2018 IE00BDGSNK96 152500 USD 2,657,634.67 17.4271
    WisdomTree India Quality UCITS ETF - USD Acc 30/11/2018 IE00BDGSNL04 222500 USD 3,886,157.30 17.4659
    WisdomTree ISEQ 20 UCITS ETF 30/11/2018 IE00BVFB1H83 1300000 EUR 15,434,387.81 11.8726
    WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc 30/11/2018 IE00BYQCZL35 215945 CHF 3,921,106.59 18.1579
    WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc 30/11/2018 IE00BYQCZJ13 825839 EUR 12,901,035.88 15.6217
    WisdomTree Japan Equity UCITS ETF - GBP Hedged 30/11/2018 IE00BYQCZF74 113978 GBP 1,194,296.85 10.4783
    WisdomTree Japan Equity UCITS ETF - JPY Acc 30/11/2018 IE00BYQCZN58 2333721 USD 43,221,932.03 18.5206
    WisdomTree Japan Equity UCITS ETF - USD Hedged 30/11/2018 IE00BVXC4854 13268036 USD 210,201,869.80 15.8427
    WisdomTree Japan Equity UCITS ETF - USD Hedged Acc 30/11/2018 IE00BYQCZD50 736932 USD 12,715,131.03 17.2541
    WisdomTree Japan SmallCap Dividend UCITS ETF - USD 30/11/2018 IE00BFXYK923 20000 USD 952,132.05 47.6066
    WisdomTree Japan SmallCap Dividend UCITS ETF - USD Acc 30/11/2018 IE00BFXYKD63 20000 USD 952,132.07 47.6066
    WisdomTree UK Equity Income UCITS ETF 30/11/2018 IE00BYPGTJ26 840000 GBP 4,309,734.13 5.1306
    WisdomTree US Equity Income UCITS ETF 30/11/2018 IE00BQZJBQ63 1516315 USD 29,551,865.12 19.4893
    WisdomTree US Equity Income UCITS ETF - EUR Hedged Acc 30/11/2018 IE00BD6RZW23 17573 EUR 292,213.05 16.6285
    WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc 30/11/2018 IE00BD6RZZ53 162189 GBP 2,424,571.40 14.949
    WisdomTree US Equity Income UCITS ETF Acc 30/11/2018 IE00BD6RZT93 274649 USD 5,271,532.46 19.1937
    WisdomTree US Multifactor UCITS ETF – USD 30/11/2018 IE00BD8ZCY59 10000 USD 493,864.16 49.3864
    WisdomTree US Multifactor UCITS ETF – USD Acc 30/11/2018 IE00BD8ZD313 10000 USD 493,864.20 49.3864
    WisdomTree US Quality Dividend Growth UCITS ETF - USD 30/11/2018 IE00BZ56RD98 42491 USD 921,857.44 21.6954
    WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc 30/11/2018 IE00BZ56RG20 687537 USD 15,409,455.21 22.4125
    WisdomTree US Small Cap Dividend UCITS ETF 30/11/2018 IE00BQZJBT94 650000 USD 12,847,239.96 19.765
    WisdomTree Artificial Intelligence UCITS ETF - USD Acc 30/11/2018 IE00BDVPNG13 40000 USD 1,006,881.52 25.172038 Reported by GlobeNewswire 1 hour ago.

    0 0

    Participants will learn fundamentals of effective coaching from Learning Forward’s senior advisor, Joellen Killion in her transformative online program

    BOSTON (PRWEB) December 03, 2018

    Recent research of over 60 studies, found that instructional coaching can improve the quality of a teacher’s instruction and lead to gains in student achievement. To meet this need, Public Consulting Group, Inc. (PCG Education), the leading provider of research-based professional learning programs, is pleased to announce the launch of its innovative online course “Effective Coaching to Strengthen Instruction,” developed in collaboration with Learning Forward, the preeminent leader dedicated to K12 professional development. As part of the annual Learning Forward Conference taking place at the Gaylord Texan Resort and Convention Center in Grapevine, TX, PCG Education will be providing course information sessions located in the Grapevine Ballroom - C.

    The course, led by Joellen Killion, senior advisor and former Deputy Executive Director of Learning Forward, addresses the need for professional development that is designed specifically for coaches, which is lacking in many districts nationwide. This type of PD will help schools improve the quality of coaching at scale by building a common language, shared goals and foundational skills, among coaching staff, leading to increased capacity and more effective instruction.

    Additionally, the course is designed to guide instructional coaches through the fundamentals of coaching teachers, to strengthen the quality of instruction for improved student academic success.Course participants will see videos of authentic coaches’ meetings and classroom instruction; have access to topical readings and publications; and engage in practice-based resources and application projects.

    “Effective Coaching to Strengthen Instruction” will help learners develop the skills they need to cultivate effective, sustainable coaching from establishing communication and learning to work with others in coaching relationships, to implementing classroom supports and the coaching cycle with teachers.

    “At Learning Forward, we strive to build leaders’ capacity to deliver effective and sustainable programs that strengthen teacher performance and improve student achievement,” said Killion.“We’re thrilled to partner with PCG Education who shares our mission of providing an online learning experience that gives participants the on-going tools and support they need to foster a coaching culture within their schools, resulting in positive systemic change.”

    The course will be delivered via PCG Education’s Professional Learning Platform, a collaborative online learning community, enabling education leaders across the country to build institutional capacity. Its self-paced, asynchronous format makes it easy for busy educators to access the course online on their own time, while practicing their skills in the classroom, and continuing their professional development using Learning Forward’s proven approach.

    “We continue to see the positive mindset shift and the powerful results that effective coaching can have within school systems,” said Alvin Crawford, General Manager of PCG Education. “Districts have invested in cadres of instructional coaches in schools. Effective coaching happens when coaches have the right professional development to develop a vision and a consistent high quality approach to coaching. We’re excited to collaborate with Learning Forward to bring this new online course to districts and schools nationwide.”

    PCG Education currently offers a diverse catalogue of innovative online courses that are taken by educators across the nation for both continuing education and graduate credit, directly helping schools and districts increase instructional coaching capacity through effective professional development that’s focused, sustained, collaborative, supported by coaching, and includes opportunities for feedback and reflection. “Effective Coaching to Strengthen Instruction” is the latest course to be offered.

    Joellen Killion, course instructor of “Effective Coaching to Strengthen Instruction” will be presenting the session, "Taking the Lead: New Roles for Teachers and School-based Coaches" at the Learning Forward Conference on Monday, December 3 from 8:30am -11:30am and continued from 2:30pm -4:30pm.

    To learn more about this course, please contact PCG Education at (800) 728-0032 or onlinepl@pcgus.com.

    About Public Consulting Group
    Public Consulting Group, Inc. (PCG) is a leading public sector solutions implementation and operations improvement firm that partners with health, education, and human services agencies to improve lives. Founded in 1986 and headquartered in Boston, Massachusetts, PCG has over 2,000 professionals in more than 50 offices around the US, in Canada and in Europe. PCG’s Education practice offers consulting services and technology solutions that help schools, school districts, and state education agencies/ministries of education to promote student success, improve programs and processes, and optimize financial resources. To learn more, visit http://www.publicconsultinggroup.com/education.

    About Learning Forward
    Learning Forward is a nonprofit, international membership association of educators committed to one vision in K–12 education: Excellent teaching and learning every day. To realize that vision, Learning Forward pursues its mission to build the capacity of leaders to establish and sustain highly effective professional learning. Information about membership, services, and products is available from http://www.learningforward.org.

    Media Contact:
    Alyssa Miller
    alyssa(at)ammediaworks(dot)com
    973.615.1292 Reported by PRWeb 1 hour ago.

    0 0

    Revenue Marketing™ Agency, The Pedowitz Group (TPG), announces Chief Strategy Officer Debbie Qaqish will present, “Time to Step-Up: Leading the Shift to Customer-Centricity” during the Salesforce 2019 World Tour in Atlanta (December 5) and New York City (December 13). During her sessions, Debbie will explain the mindset, skillset and toolset required for today's customer-centric marketer.

    ATLANTA (PRWEB) December 03, 2018

    Revenue Marketing™ Agency, The Pedowitz Group (TPG), announces Chief Strategy Officer Debbie Qaqish will present, “Time to Step-Up: Leading the Shift to Customer-Centricity” during the Salesforce 2019 World Tour in Atlanta (December 5) and New York City (December 13). During her sessions, Debbie will explain the mindset, skillset and toolset required for today's customer-centric marketer. Attendees will gain a fresh perspective on their role in leading and operationalizing the vital shift to customer-centricity.

    The Atlanta tour on December 5 will be held at the Georgia World Congress Center with 1,500+ expected to attend. Debbie will speak from 12:45 – 1:05pm ET. Register here. Sessions are free and open to the public. The New York City tour on December 13 at the Javitz Convention Center is expected to attract 5,000+. Register here to attend Debbie’s session, 9:15 – 9:35am.

    “In today’s customer-driven economy, embracing a customer-centric model is now a business imperative for survival and growth,” Debbie notes. “Leading and operationalizing a customer-centric philosophy represents the single biggest challenge and the single biggest opportunity facing marketers today.”

    The Pedowitz Group is a registered Salesforce.com Marketing Cloud partner and a Platinum sponsor for the 2019 Salesforce World Tour in Atlanta and New York. Visit TPG in Atlanta at the Georgia World Congress Center in booth # 127 and in NYC at the Javitz Convention Center (check marquis for booth #).

    About Debbie Qaqish

    Debbie Qaqish has been inspiring B2B marketers to embrace revenue accountability for over 35 years. As Principal Partner and Chief Strategy Officer of TPG, she manages global client relationships and leads the firm’s thought leadership initiatives.

    Debbie authored the award winning book – “Rise of the Revenue Marketer.” She is Chancellor of Revenue Marketing University and host of Revenue Marketing Radio, which showcases marketing executives from companies like GE and Microsoft sharing advice on marketing transformation. Her second book, “The Rise of the Strategic Marketing Operations Function,” will be published in early 2019. A PhD candidate, Debbie teaches an MBA course at College of William & Mary on Revenue Marketing.

    For the last six years, Debbie has been named One of the 50 Most Influential People in Sales Lead Management. She has also won SLMA’s Top 20 Women to Watch distinction for four years. Kapost named Debbie among the Top 40 Most Inspiring Women in Marketing. FierceCMO Magazine named Debbie one of the Top 10 Women CMOs to Watch.

    Debbie writes a regular column for AMA B2B Insights, MarTech Today, MarTech Advisor and MarTech Series. She speaks regularly at industry events including Scott Brinker’s MarTech Conferences and serves on the Board of Advisors for the Sales Lead Management Association.    

    About Salesforce

    Salesforce, the global CRM leader, empowers companies to connect with their customers in a whole new way. For more information about Salesforce (NYSE: CRM). Salesforce has headquarters in San Francisco, with offices in Europe and Asia. For more information please visit https://www.salesforce.com or call 1-800-NO-SOFTWARE.

    About The Pedowitz Group – Connecting Marketing to Revenue™

    The Pedowitz Group (TPG) wrote the book, and is the undisputed thought leader on Revenue Marketing™. As a partner, The Pedowitz Group (TPG) helps companies plan, build and optimize their revenue engine by delivering services in MarTech, demand generation and marketing operations. TPG believes that Marketing is the driver of customer engagement that fuels the revenue engine. The Pedowitz Group customers have won over 50 national awards for their Revenue Marketing excellence. To discover how we can help your organization become a successful Revenue Marketer™, visit https://www.pedowitzgroup.com, or call us at 855-REV-MKTG or visit Revenue Marketer Blog. Reported by PRWeb 1 hour ago.

    0 0

    Turing-Powered TITAN Delivers 130 Teraflops of Deep Learning Horsepower, 11 GigaRays of Ray-Tracing Performance to World’s Most Demanding Users

    MONTREAL, Dec. 03, 2018 (GLOBE NEWSWIRE) -- *Conference on Neural Information Processing Systems—*NVIDIA today introduced NVIDIA® TITAN RTX™, the world’s most powerful desktop GPU, providing massive performance for AI research, data science and creative applications.Driven by the new NVIDIA Turing™ architecture, TITAN RTX — dubbed T-Rex — delivers 130 teraflops of deep learning performance and 11 GigaRays of ray-tracing performance.

    “Turing is NVIDIA’s biggest advance in a decade – fusing shaders, ray tracing, and deep learning to reinvent the GPU,” said Jensen Huang, founder and CEO of NVIDIA. “The introduction of T-Rex puts Turing within reach of millions of the most demanding PC users — developers, scientists and content creators.”

    *Ultimate PC GPU*
    NVIDIA’s greatest leap since the invention of the CUDA® GPU in 2006 and the result of more than 10,000 engineering-years of effort, Turing features new RT Cores to accelerate ray tracing, plus new multi-precision Tensor Cores for AI training and inferencing. These two engines — along with more powerful compute and enhanced rasterization — enable capabilities that will transform the work of millions of developers, designers and artists across multiple industries.

    Designed for a variety of computationally demanding applications, TITAN RTX provides an unbeatable combination of AI, real-time ray-traced graphics, next-gen virtual reality and high performance computing. It delivers:

    · 576 multi-precision Turing Tensor Cores, providing up to 130 teraflops of deep learning performance.
    · 72 Turing RT Cores, delivering up to 11 GigaRays per second of real-time ray-tracing performance.
    · 24GB of high-speed GDDR6 memory with 672GB/s of bandwidth — 2x the memory of previous-generation TITAN GPUs — to fit larger models and datasets.
    · 100GB/s NVIDIA NVLink® can pair two TITAN RTX GPUs to scale memory and compute.
    · Incredible performance and memory bandwidth for real-time 8K video editing.
    · VirtualLink™ port provides the performance and connectivity required by next-gen VR headsets.

    *Built for AI Researchers and Deep Learning Developers*
    TITAN RTX transforms the PC into a supercomputer for AI researchers and developers. TITAN RTX provides multi-precision Turing Tensor Cores for breakthrough performance from FP32, FP16, INT8 and INT4, allowing faster training and inference of neural networks. It offers twice the memory capacity of previous generation TITAN GPUs, along with NVLink to allow researchers to experiment with larger neural networks and data sets.

    *Perfect for Data Scientists*
    A powerful tool for data scientists, TITAN RTX accelerates data analytics with RAPIDS. RAPIDS open-source libraries integrate seamlessly with the world’s most popular data science workflows to speed up machine learning.

    *Content Creators Create Their Best Work*
    TITAN RTX brings the power of real-time ray tracing and AI to creative applications, so 5 million PC-based creators can iterate faster. It also delivers the computational horsepower and memory bandwidth needed for real-time 8K video editing.

    *Available This Month*
    TITAN RTX will be available later this month in the U.S. and Europe for $2,499.

    *About NVIDIA*
    NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market, redefined modern computer graphics and revolutionized parallel computing. More recently, GPU deep learning ignited modern AI — the next era of computing — with the GPU acting as the brain of computers, robots and self-driving cars that can perceive and understand the world. More information at http://nvidianews.nvidia.com/.

    *For further information, contact:*
    Ken Brown
    Director, Corporate Communications
    NVIDIA
    +1-510-290-2603
    kebrown@nvidia.com

    Certain statements in this press release including, but not limited to, statements as to: the performance, benefits, abilities and availability of the NVIDIA TITAN RTX, including its deep learning and ray-tracing performance, memory, compute, video editing and VirtualLink port which provides the performance and connectivity required by next-gen head-mounted displays; NVIDIA TITAN RTX being the world’s most powerful desktop GPU and providing massive performance; Turing representing NVIDIA’s most revolutionary advance in more than a decade, and it delivering a new era in graphics and AI; NVIDIA TITAN RTX putting Turing in within reach of millions of the most demanding PC users; Turing being NVIDIA’s greatest leap since the invention of CUDA; the number of engineering-years of effort to develop Turing; Turing’s features, including RT Cores and Tensor Cores; RT Cores and Tensor Cores enabling capabilities that will transform the work of millions of developers, designers and artists across industries; TITAN RTX providing an unbeatable combination of AI, graphics, virtual reality and high performance computing; TITAN RTX transforming a PC into a supercomputer and its features allowing for faster training and inference of neural networks; TITAN RTX accelerating data analytics with RAPIDS which integrate into data science workflows and speeding up machine learning; and TITAN RTX’s ability to bring real-time ray tracing to creative applications so PC-based creators can iterate faster and delivering computational horsepower and memory bandwidth for video editing are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners' products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company's website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

    © 2018 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, TITAN RTX, NVIDIA Turing, CUDA, NVIDIA NVLink and RAPIDS are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries. Other company and product names may be trademarks of the respective companies with which they are associated. Features, pricing, availability and specifications are subject to change without notice.

    A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/174bea4d-d7a9-4efb-9cb2-07093bbe48fe  Reported by GlobeNewswire 1 hour ago.

    0 0

    Workspace ONE Recognized with Highest Possible Score in Identity and Access Management (IAM), Application, Data, and Network Security Criteria

    PALO ALTO, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- VMware, Inc. (NYSE: VMW), a leading innovator in enterprise software, today announced it has been positioned as a leader in The Forrester Wave™: Unified Endpoint Management, Q4 2018, which evaluated 12 unified endpoint management (UEM) vendors. VMware’s intelligence-driven digital workspace platform, VMware Workspace ONE, achieved the highest possible score in the market presence category, as well as the product vision, commitment to innovation, and partner ecosystem criteria.According to the Forrester Wave report, “Over the past year, VMware has invested heavily in helping customers embrace modern management for Windows 10 with its Workspace ONE product. The solution’s differentiated AirLift feature automates migration of SCCM collections, devices, and app packages to Workspace ONE. It excels in IAM, with features like single sign-on (SSO) to the Workspace ONE app and support for dozens of conditional access policies.”

    VMware continues to deliver on new innovations that make Workspace ONE the industry’s digital workspace platform of choice for IT and employees. From apps to mobile devices to PCs, VMware Workspace ONE UEM provides employees with a single console to manage and better secure their most critical business apps and devices across all platforms, including Windows, macOS, Chrome OS, iOS, and Android. Workspace ONE UEM delivers an automated and on-demand workspace environment with greater flexibility and at lower costs for an intuitive, more secure experience for all employees, both inside and outside the office.

    “By helping customers manage and better secure more devices and OS platforms, more apps, and more clouds with Workspace ONE, VMware is uniquely positioned to help them embrace the technology heterogeneity that is commonplace in today’s workplace,” said Noah Wasmer, senior vice president and general manager, End-User Computing, VMware. “We are proud of the fact that our broad platform support, deep management and security capabilities, and expansive partner ecosystem are leading the industry and, we believe, have earned us recognition from today’s leading analysts.”

    To download “The Forrester Wave™: Unified Endpoint Management, Q4 2018” report, click here.

    *Additional Resources *

    · Read how VMware was also named a leader in the IDC MarketScape for Unified Endpoint Management Software 2018 Vendor Assessment and the Gartner Magic Quadrant for Unified Endpoint Management Tools­­
    · Learn about the new Workspace ONE innovations that were recently unveiled at VMworld 2018 Europe
    · Bookmark the VMware End-User Computing Blog
    · Follow VMware on Facebook, LinkedIn and Twitter

    VMware and Workspace ONE are registered trademarks or trademarks of VMware, Inc. or its subsidiaries in the United States and other jurisdictions.

    This article may contain hyperlinks to non-VMware websites that are created and maintained by third parties who are solely responsible for the content on such websites.*About VMware *
    VMware software powers the world’s complex digital infrastructure. The company’s compute, cloud, mobility, networking and security offerings provide a dynamic and efficient digital foundation to over 500,000 customers globally, aided by an ecosystem of 75,000 partners. Headquartered in Palo Alto, California, this year VMware celebrates twenty years of breakthrough innovation benefiting business and society. For more information, please visit https://www.vmware.com/company.html.

    *Media Contact*
    Angela Leaf                                                     
    VMware Global Communications                       
    Phone: +1 860 480 3367                       
    aleaf@vmware.com                   Reported by GlobeNewswire 1 hour ago.

    0 0

    Neil Warnock: Cardiff City manager looks to recruit from Europe BBC Local News: South West Wales -- Manager Neil Warnock and members of his staff will seek January transfers from clubs in Europe as they bid to survive in the Premier League. Reported by BBC Local News 1 hour ago.

    0 0

    Neil Warnock Cardiff City manager looks to recruit from Europe BBC Local News: South East Wales -- Manager Neil Warnock and members of his staff will seek January transfers from clubs in Europe as they bid to survive in the Premier League. Reported by BBC Local News 1 hour ago.

    0 0

    PLANO, Texas, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it has received U.S. Food and Drug Administration (FDA) head-only MR-conditional approval for the Company’s Algovita SCS system.Scott Drees, Chief Executive Officer, commented, “This FDA approval represents our continued commitment to the advancement of the Algovita system and further enhances our competitive positioning. We believe that the addition of a head-only MR-conditional label will drive increased adoption of our system. As we prepare to submit an application for full-body MR-conditional approval with the FDA in early 2019, we look forward to continued growth in the United States.”

    *About Nuvectra Corporation*

    Nuvectra^® is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita^® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease. In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com

    *Cautionary Note Regarding Forward-Looking Statements*

    This press release contains "forward-looking statements," including statements we make regarding the outlook for Nuvectra as an independent publicly-traded company. Forward-looking statements are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions, and therefore they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and may be outside of our control. Our actual performance may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Any forward-looking statement made by us is based only on information currently available to us and speaks only as of the date on which it is made.  Important factors that could cause our actual results to differ materially from those indicated in the forward-looking statements include: (i) our ability to successfully commercialize Algovita and to develop, complete and commercialize enhancements or improvements to Algovita; (ii) our ability to successfully compete with our current SCS competitors and the ability of our U.S. sales representatives to successfully establish market share and acceptance of Algovita, (iii) the uncertainty and timing of obtaining regulatory approvals in the United States and Europe for our Virtis SNM system, (iv) our ability to successfully launch and commercialize the Virtis SNM system if and when it receives regulatory approval (v) our ability to demonstrate the features, perceived benefits and capabilities of Algovita to physicians and patients in competition with similar products already well established and sold in the SCS market; (vi) our ability to anticipate and satisfy customer needs and preferences and to develop, introduce and commercialize new products or advancements and improvements to Algovita in order to successfully meet our customers’ expectations; (vii) the outcome of our development plans for our neurostimulation technology platform, including our ability to identify additional indications or conditions for which we may develop neurostimulation medical devices or therapies and seek regulatory approval thereof; (viii) our ability to identify business development and growth opportunities and to successfully execute on our strategy, including our ability to seek and develop strategic partnerships with third parties to, among other things, fund clinical and development costs for new product offerings; (ix) the performance by our development partners, including Aleva Neurotherapeutics, S.A., of their obligations under their agreements with us; (x) the scope of protection for our intellectual property rights covering Algovita and other products using our neurostimulation technology platform, along with any product enhancements or improvements; (xi) our ability to successfully build, attract and maintain an effective commercial infrastructure and qualified sales force in the United States; (xii) our compliance with all regulatory and legal requirements regarding implantable medical devices and interactions with healthcare professionals; (xiii) our reliance on each of Integer, our exclusive and sole manufacturer and supplier of parts and components for Algovita, and Minnetronix, Inc., our sole-source supplier of external peripheral devices; (xiv) any supplier shortages related to Algovita or its components and any manufacturing disruptions which may impact our inventory supply as we expand our business; (xv) any product recalls, or the receipt of any warning letters, mandatory corrections or fines from any governmental or regulatory agency; (xvi) our ability to satisfy the conditions and covenants of our Credit Facility; and (xvii) our ability to raise capital should it become necessary to do so, through another public offering of our common stock, private equity or debt financings, strategic partnerships, or other sources. Please see the section entitled “Risk Factors” in Nuvectra’s Annual Report on Form 10-K and in our other quarterly and periodic filings for a description of these and other risks and uncertainties.  We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

    *Company Contacts:* * * * * * * * * *Investor Contacts:* * * * *
    *Nuvectra Corporation* * * * * * * * * *The Ruth Group* * * * *
                   
    Walter Berger, COO & CFO         Tram Bui / Brian Johnston    
    (214) 474-3102         (646) 536-7035 / 7028    
    wberger@nuvectramed.com         investors@nuvectramed.com     Reported by GlobeNewswire 1 hour ago.

    0 0

    · *Emission-free, energy-efficient and low-noise: Jury applauds Bombardier's new battery-powered train as a pioneering contribution to clean rail mobility*

    BERLIN, Dec. 03, 2018 (GLOBE NEWSWIRE) --

    Note to editors: To view the photos associated with this press release, please visit the following links:

    http://www.globenewswire.com/NewsRoom/AttachmentNg/763c30cd-0747-434b-992f-2bd7eb8bce04

    http://www.globenewswire.com/NewsRoom/AttachmentNg/74361015-739d-4005-b10d-e6901e96e26c

    The BOMBARDIER TALENT 3 battery electric multiple unit was awarded the renowned Berlin Brandenburg innovation award on November 30, 2018. The train operates emission-free, thereby making a significant contribution towards environmentally-friendly mobility. It can be used to bridge non-electrified lines and replace diesel trains with clean battery-powered vehicles.

    A distinguished, 17-member jury selected the battery-powered multiple unit as one of the winners from among ten finalists. Bombardier will allocate the prize money of 10,000 euros to promote innovation and social responsibility. One part will be used to organize a hackathon event with (disadvantaged) youth and students on the topic "Train of the Future", in cooperation with Technische Universität Berlin (TU Berlin). The other part will be donated to the Children’s Hospice Sonnenhof in Berlin.

    "This award is a great testament to our team’s accomplishments and our commitment to deliver innovative and high-performing products that solve some of the biggest environmental and mobility challenges today,” said Pierre-Yves Cohen, President, responsible for products and engineering at Bombardier Transportation. "It was our goal to develop a quiet and eco-friendly train for passengers, while also offering operators worldwide the best alternative to high-emission diesel trains on both cost and safety aspects. We are very proud that next year the TALENT 3 battery-powered train will be the first to enter passenger service in Europe in over 60 years.”

    Michael Fohrer, Head of Bombardier Transportation in Germany, added, "Smart, innovative and forward-looking – this train masters all the challenges of modern mobility. It is a prime example of Bombardier's innovative strength in Germany. Forty per cent of the domestic rail network is not electrified. Bombardier’s battery-operated train is an economically and ecologically attractive option for these lines.”

    With its ultra-fast charging, high-performance BOMBARDIER MITRAC lithium-ion batteries, the TALENT 3 battery train could already operate on more than 30 per cent of Germany’s non-electrified lines today. Thanks to cost-effective electrification of the end points, even 75 per cent of all diesel lines in Germany could be operated with battery-power, and without having to change trains. According to an independent comparative study by Technische Universität Dresden (TU Dresden), the battery train would be the most cost-effective and CO[2]-free alternative to diesel trains in terms of total cost of ownership over the entire 30-year service life.

    The train’s batteries are charged while driving, or at stations under the overhead line, or with the aid of recovered braking energy. As soon as the train travels on non-electrified lines, the batteries mounted on the roof supply the required electricity in an ecological and efficient way.

    The battery electric multiple unit was developed in cooperation with various project partners. These include the DB Regio subsidiary DB ZugBus Regionalverkehr Alb-Bodensee (regional transport for the Lake Constance region), Nahverkehrsgesellschaft Baden-Württemberg (Baden-Wuerttemberg Regional Transport Company) and the Nationale Organisation Wasserstoff- und Brennstoffzellentechnologie (National Organisation for Hydrogen and Fuel Cell Technology) and TU Berlin. Germany’s Federal Ministry of Transport and Digital Infrastructure (BMVI) contributed to the funding of the project with a grant of four million euros.

    *About Bombardier Transportation
    *Bombardier Transportation is a global mobility solution provider leading the way with the rail industry’s broadest portfolio. It covers the full spectrum of solutions, ranging from trains to sub-systems and signalling to complete turnkey transport systems, e-mobility technology and data-driven maintenance services. Combining technology and performance with empathy, Bombardier Transportation continuously breaks new ground in sustainable mobility by providing integrated solutions that create substantial benefits for operators, passengers and the environment. Headquartered in Berlin, Germany, Bombardier Transportation employs around 39,850 people and its products and services operate in over 60 countries.

    *About Bombardier
    *With over 69,500 employees across four business segments, Bombardier is a global leader in the transportation industry, creating innovative and game-changing planes and trains. Our products and services provide world-class transportation experiences that set new standards in passenger comfort, energy efficiency, reliability and safety.

    Headquartered in Montreal, Canada, Bombardier has production and engineering sites in 28 countries across the segments of Transportation, Business Aircraft, Commercial Aircraft and Aerostructures and Engineering Services. Bombardier shares are traded on the Toronto Stock Exchange (BBD). In the fiscal year ended December 31, 2017, Bombardier posted revenues of $16.2 billion US. News and information are available at bombardier.com or follow us on Twitter @Bombardier.

    *Notes to editors
    *For news, related material and photos, visit our newsroom at www.rail.bombardier.com/en/newsroom.html. Please subscribe to our RSS Feed to receive press releases or follow Bombardier Transportation on Twitter @BombardierRail.

    Bombardier and TALENT are trademarks of Bombardier Inc. or its subsidiaries.

    *For information*

    *Media relations, Germany*
    Andreas Dienemann
    +49 3302 89 4260 
    +49 174 920 1431
    andreas.dienemann@rail.bombardier.com
    *Global media relations*
    +49 30 98607 1687
    press@rail.bombardier.com

    You can also contact one of our worldwide contacts for specific press inquiries. Reported by GlobeNewswire 1 hour ago.

    0 0

    · *U.S. launch scheduled for early in the first quarter of 2019 *
     
    · *Catalyst is well-capitalized and sees no current need for capital infusion*

    CORAL GABLES, Fla., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases today announced that the company will host a conference call and webcast on December 13, 2018 at 8:30 AM ET to discuss its commercialization plan for Firdapse®, including the cost of therapy. Firdapse will be available early in the first quarter of 2019.

    “We look forward to providing the details of the commercial launch plan for Firdapse for the treatment of LEMS, as well as our plan for achieving our stated objective of affordable access to Firdapse for all,” said Patrick J. McEnany, Chairman and Chief Executive Officer of Catalyst Pharmaceuticals. “We are well-capitalized to support the launch of Firdapse, and as we have stated in our recent public filings we have sufficient cash to execute our business plan through at least 2019.”

    Investors who wish to participate in the conference call may do so by dialing (877) 407-8912 for domestic and Canadian callers or (201) 689-8059 for international callers. Those interested in listening to the conference call live via the internet may do so by visiting the Investors page of the company's website at www.catalystpharma.com and clicking on the webcast link on the Investors home page.

    A webcast replay will be available on the Catalyst website following the call by visiting the Investor page of the company's website at www.catalystpharma.com.

    *About Firdapse® (amifampridine)*
    Firdapse® (amifampridine) 10 mg tablets is an oral, nonspecific, voltage-dependent, potassium (K+) channel blocker that causes depolarization of the presynaptic membrane and slows or inhibits repolarization. This action results in the opening of slow voltage-dependent calcium (Ca2+) channels, allowing for a subsequent influx of Ca2+. In turn, it induces the exocytosis of synaptic vesicles containing Acetylcholine (ACh) to release more ACh into the synaptic cleft, enhancing neuromuscular transmission, and providing for improved muscle function. Firdapse is approved in the U.S. and the European Union for use by patients with LEMS.

    *About Catalyst Pharmaceuticals*
    Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, including LEMS, congenital myasthenic syndromes (CMS), MuSK antibody positive myasthenia gravis (MuSK-MG), and spinal muscular atrophy (SMA) type 3. Amifampridine phosphate has received Orphan Drug Designation from the United States FDA for CMS and myasthenia gravis. Firdapse (amifampridine) 10 mg tablets is the first and only approved drug in Europe for symptomatic treatment in adults with LEMS.

    Catalyst is also developing a generic version of vigabatrin.

    *Forward-Looking Statements
    *This press release contains forward-looking statements. Forward-looking statements involve known and unknown risks and uncertainties, which may cause Catalyst's actual results in future periods to differ materially from forecasted results. A number of factors, including (i) whether Catalyst will be successful in commercializing Firdapse (ii) whether, even if Catalyst is successful in commercializing Firdapse, Catalyst will become profitable, (iii) whether Firdapse will ever be approved for the treatment of CMS, MuSK-MG, SMA type 3, or any other disease, and (iv) those other factors described in Catalyst's Annual Report on Form 10-K for the fiscal year 2017 and its other filings with the U.S. Securities and Exchange Commission (SEC), could adversely affect Catalyst. Copies of Catalyst's filings with the SEC are available from the SEC, may be found on Catalyst's website, or may be obtained upon request from Catalyst. Catalyst does not undertake any obligation to update the information contained herein, which speaks only as of this date.

    CONTACT: Investor Contact
    Brian Korb, Solebury Trout
    (646) 378-2923
    bkorb@troutgroup.com

    Company Contact
    Patrick J. McEnany, Catalyst Pharmaceuticals
    Chief Executive Officer
    (305) 420-3200
    pmcenany@catalystpharma.com

    Media Contact
    David Schull, Russo Partners
    (212) 845-4271
    david.schull@russopartnersllc.com Reported by GlobeNewswire 1 hour ago.

    0 0

    I’ll be heading back to Europe on December 18th to run a pitch-off in Wroclaw, Poland. It’s a bit out of the way but well worth a visit if only for the sausages. The event called In-Ference is happening on December 17 and you can submit to pitch here. The team will notify you if […] Reported by TechCrunch 52 minutes ago.

    0 0

    Dublin, Dec. 03, 2018 (GLOBE NEWSWIRE) -- The "Global Vacuum Insulation Panels Market Analysis & Trends - Industry Forecast to 2027" report has been added to *ResearchAndMarkets.com's* offering.

    The Global Vacuum Insulation Panels Market is poised to grow strong during the forecast period 2017 to 2027. Some of the prominent trends that the market is witnessing include rise in demand for VIPs in emerging economies, growing adoption of VIPs for automated storage and retrieval and increasing focus on energy-efficient practices.

    This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027.

    The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

    *Scope of the Report*· Based on Raw Material, the market is categorized into Plastics, Metal and Other Raw Material.
    · Other Raw Material is sub segmented into Glass and Microfleece.
    · By Structure Type, market is segregated by Special Shape and Flat.
    · Based on Core Material, the market is categorized into Fiberglass, Silica and Other Core Materials.
    · Moreover, Silica segment is sub divided into Fumed Silica and Precipitated Silica.
    · Other Core Materials is sub segmented into Aerogel, Polyurethane Board and Micro-Fleece Board.
    · Based on Application, the market is categorized into Construction, Logistics, Cooling & Freezing Devices and Other Applications.
    · Further, Construction segment is sub divided into Floor Insulation, Roof & Terrace Insulation, Facades and Other Construction Application.
    · Other Applications is sub segmented into Storage, Packaging and Industrial & Automotive Applications.

    *Report Highlights:*

    · The report provides a detailed analysis on current and future market trends to identify the investment opportunities
    · Market forecasts till 2027, using estimated market values as the base numbers
    · Key market trends across the business segments, Regions and Countries
    · Key developments and strategies observed in the market
    · Market Dynamics such as Drivers, Restraints, Opportunities and other trends
    · In-depth company profiles of key players and upcoming prominent players
    · Growth prospects among the emerging nations through 2027
    · Market opportunities and recommendations for new investments

    *Key Topics Covered:*

    *1 Market Outline*
    1.1 Research Methodology
    1.2 Market Trends
    1.3 Regulatory Factors
    1.4 Application Analysis
    1.5 Strategic Benchmarking
    1.6 Opportunity Analysis

    *2 Executive Summary*

    *3 Market Overview*
    3.1 Current Trends
    3.1.1 Rise in Demand for VIPs in Emerging Economies
    3.1.2 Growing Adoption of VIPs for Automated Storage and Retrieval
    3.1.3 Increasing Focus on Energy-Efficient Practices
    3.1.4 Growth Opportunities/Investment Opportunities
    3.2 Drivers
    3.3 Constraints
    3.4 Industry Attractiveness

    *4 Vacuum Insulation Panels Market, By Raw Material*
    4.1 Plastics
    4.2 Metal
    4.3 Other Raw Materiall
    4.3.1 Glass
    4.3.2 Microfleece

    *5 Vacuum Insulation Panels Market, By Structure Type*
    5.1 Special Shape
    5.2 Flat

    *6 Vacuum Insulation Panels Market, By Core Material*
    6.1 Fiberglass
    6.2 Silica
    6.2.1 Fumed Silica
    6.2.2 Precipitated Silica
    6.3 Other Core Materials
    6.3.1 Aerogel
    6.3.2 Polyurethane Board
    6.3.3 Micro-Fleece Board

    *7 Vacuum Insulation Panels Market, By Application*
    7.1 Construction
    7.1.1 Floor Insulation
    7.1.2 Roof & Terrace Insulation
    7.1.3 Facades
    7.1.4 Other Construction Application
    7.2 Logistics
    7.3 Cooling & Freezing Devices
    7.4 Other Applications
    7.4.1 Storage
    7.4.2 Packaging
    7.4.3 Industrial & Automotive Applications

    *8 Vacuum Insulation Panels Market, By Geography*
    8.1 North America
    8.1.1 US
    8.1.2 Canada
    8.1.3 Mexico
    8.2 Europe
    8.2.1 Germany
    8.2.2 U.K
    8.2.3 Italy
    8.2.4 France
    8.2.5 Spain
    8.2.6 Rest of Europe
    8.3 Asia Pacific
    8.3.1 China
    8.3.2 Japan
    8.3.3 India
    8.3.4 Australia
    8.3.5 New Zealand
    8.3.6 Rest of Asia Pacific
    8.4 Middle East
    8.4.1 Saudi Arabia
    8.4.2 UAE
    8.4.3 Rest of Middle East
    8.5 Latin America
    8.5.1 Argentina
    8.5.2 Brazil
    8.5.3 Rest of Latin America
    8.6 Rest of the World (RoW)
    8.6.1 South Africa
    8.6.2 Others

    *9 Key Player Activities*
    9.1 Acquisitions & Mergers
    9.2 Agreements, Partnerships, Collaborations and Joint Ventures
    9.3 Product Launch & Expansions
    9.4 Other Activities

    *10 Leading Companies*
    10.1 BASF SE
    10.2 Evonik Industries AG
    10.3 Panasonic Corp
    10.4 DOW Corning Corp
    10.5 Rockwool International
    10.6 Sealed Air Corporation
    10.7 OCI Company Ltd.
    10.8 Sonoco
    10.9 LG Hausys Ltd.
    10.10 Fujian Super Tech Advanced Material
    10.11 American Aerogel Corporation
    10.12 Cryopak
    10.13 Sofrigram SA Ltd
    10.14 Cold Chain Technologies
    10.15 Porextherm Dmmstoffe GmbH
    10.16 Pelican Biothermal
    10.17 Thermal Visions
    10.18 Thermocor
    10.19 Vacutherm Ltd
    10.20 Va-Q-Tec AG
    10.21 Hanita Coatings
    10.22 Kevothermal, LLC
    10.23 Kingspan Insulation

    For more information about this report visit https://www.researchandmarkets.com/research/zc84n4/global_vacuum?w=12

    Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

    CONTACT:
    CONTACT: ResearchAndMarkets.com
    Laura Wood, Senior Press Manager
    press@researchandmarkets.com
    For E.S.T Office Hours Call 1-917-300-0470
    For U.S./CAN Toll Free Call 1-800-526-8630
    For GMT Office Hours Call +353-1-416-8900
    Related Topics: Insulation Reported by GlobeNewswire 1 hour ago.

older | 1 | .... | 1560 | 1561 | (Page 1562) | 1563 | 1564 | .... | 1652 | newer